CardiOS is a unique formulation which simultaneously targets cardiovascular, bone health and declining DHEA-Cortisol balance, all of which significantly deteriorate during the ageing process.
The formulated ingredients in CardiOS are designed to favourably contribute to reducing these combined elements of chronic disease.
Out of stock
CardiOS is beneficial for those approaching mid and later-life to support declining physiology, especially common to both Andropausal men and Menopausal & Post-Menopausal women.
CardiOS is indicated for:
Serving Type: Vegetable Cellulose Size ’00’ Capsule (suitable for vegetarians).
Clinical data shows that compounds in CardiOS may:
Each Size ‘00’ CardiOS VegeCap® contains:
NOTE: Cell-Logic EnduraCell® is hydroganically grown in a carefully controlled environment to maximise bioactivity. Our hydroganic growing process does not use any herbicides, pesticides or other harmful chemicals. CardiOS is GMO free.
Recommended Daily Dosage:
Adults: Take 1 capsule twice daily or as directed by a Health Care Practitioner.
Children: Not recommended for children.
While Vitamin K2 appears not to interfere with coagulation, it is recommended that the patient’s clinician be consulted prior to prescription of CardiOS.
Vitamin supplements should not replace a balanced diet.
Store below 30°C away from light and moisture. May be refrigerated.
Very occasionally, gastro-intestinal adverse effects have been reported, and include nausea, gastro-abdominal discomfort and diarrhoea. Limited data available seem to indicate that such effects are limited to certain pre-existing gastro-intestinal conditions, in particular, those with dysbiosis. However, it has been observed that for those affected, the dose can be titrated so that symptoms disappear and may not recur even after the consumption of larger doses. Download our Product Advisory Statement.
Bolland MJ et al. Calcium intake and risk of fracture: systematic review BMJ 2015;351:h4580
McCann JC, Ames BN. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of ageing? Am J Clin Nutr. 2009;90:889-907
Knapen MH et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis. Int. 2013 Sep;24(9):2499-507.
Knapen MH et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost. 2015 May;113(5):1135-44.
Auddy B et al. A Standardized Withania Somnifera Extract Significantly Reduced Stress-Related Parameters in Chronically-Stressed Humans: A Double-Blind, Randomized, Placebo-Controlled Study. JANA Vol. 11(1):2008.50-56